Previous 10 | Next 10 |
2023-03-12 13:00:16 ET New weight loss therapies could cause a significant strain on Medicare due to cost implications, a group of health experts warned last week in an article published in The New England Journal of Medicine on Saturday amid legislative efforts to gain coverage. ...
2023-03-07 14:23:25 ET Penny stocks are stocks of small-cap companies that trade for less than $5 per share. Among these stocks, those that trade for less than $1 per share are often called “ penny stocks .” These stocks are known for their high volatility and low liquidit...
Company preparing to initiate Phase 3 clinical trials of TTP399, an adjunctive therapy to insulin, for the treatment of Type 1 diabetes Biotech industry and Wall Street veteran Steven Tuch appointed Executive Vice President and Chief Financial Officer Biotech industry ve...
2023-03-06 12:19:03 ET Finding the best penny stocks to buy seems easy. Just set your screener to include all stocks under $5 and start trading. While the practice may seem “easy,” identifying good penny stocks to buy is another topic of discussion. Depending on your t...
Cantex and Miami Cancer Institute Announce FDA Clearance for a Clinical Trial Investigating Azeliragon Combined with Stereotactic Radiosurgery for the Treatment of Brain Metastases PR Newswire WESTON, Fla. , March 6, 2023 /PRNewswire/ -- Cantex Pharmaceuticals, I...
Cantex Receives FDA "Study May Proceed" Letter for Phase 2 Clinical Trial of Azeliragon for the Treatment of Unmethylated Glioblastoma PR Newswire Cantex is developing azeliragon as a once-a-day pill for the treatment of glioblastoma and other cancers WESTON, Fla. ...
CANTEX PHARMACEUTICALS RECEIVES FDA ORPHAN DRUG DESIGNATION FOR AZELIRAGON FOR THE TREATMENT OF GLIOBLASTOMA PR Newswire WESTON, Fla. , Jan. 9, 2023 /PRNewswire/ -- Cantex Pharmaceuticals, Inc., a clinical-stage pharmaceutical company focused on developing transf...
InvestorPlace - Stock Market News, Stock Advice & Trading Tips Choosing the best drug stocks to buy can be dicey because drug stocks have disadvantages and advantages. On the negative side, you often have to wait many years for promising drugs to prove themselves in clinical trials. ...
vTv Therapeutics ( NASDAQ: VTVT ) has appointed biotech industry veteran Steven Tuch as CFO, effective immediately. Tuch has over 20 years of financial and business development experience with multiple life science companies through various stages of financial planning and develop...
Steven Tuch, Chief Financial Officer HIGH POINT, N.C., Dec. 13, 2022 (GLOBE NEWSWIRE) -- vTv Therapeutics Inc. (Nasdaq: VTVT), a clinical stage biopharmaceutical company focused on the development of orally administered treatments for type 1 diabetes (T1D), today announced the appointment...
News, Short Squeeze, Breakout and More Instantly...
vTv Therapeutics Inc. Company Name:
VTVT Stock Symbol:
NASDAQ Market:
vTv Therapeutics Inc. Website:
HIGH POINT, N.C., July 26, 2024 (GLOBE NEWSWIRE) -- vTv Therapeutics Inc. (Nasdaq: VTVT), a late stage biopharmaceutical company with an innovative clinical portfolio of small molecules and lead program in diabetes, today announced that the United States Food and Drug Administration (FDA) has pla...
2024-06-26 16:04:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...
Cadisegliatin is a potential first-in-class oral liver selective glucokinase activator for T1D, which has been granted Breakthrough Therapy designation by the FDA for T1D Cadisegliatin has been dosed in over ...